Phathom Pharmaceuticals Ownership 2024 | Who Owns Phathom Pharmaceuticals Now?
Institutional Ownership
25.88%
Insider Ownership
7.82%
Retail Ownership
66.30%
Institutional Holders
35.00
Phathom Pharmaceuticals Institutional Shareholders
Institutional Shareholders by % of Total Shares
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| FRAZIER LIFE SCIENCES MANAGEMENT, L.P. | 17.32% | 4.87% | 10,109,279 | - | - | 104,125,574 | Jun 30, 2024 |
| MEDICXI VENTURES MANAGEMENT (JERSEY) LTD | 12.79% | 22.93% | 7,464,572 | - | - | 76,885,092 | Jun 30, 2024 |
| CARLYLE GROUP INC. | 5.99% | 3.40% | 3,496,808 | - | - | 35,842,282 | Jun 30, 2024 |
| INVESCO LTD. | 5.39% | 0.01% | 3,143,452 | -16,337 | -0.52% | 32,377,556 | Jun 30, 2024 |
| BLACKROCK INC. | 5.01% | 0.00% | 2,926,373 | 180,993 | 6.59% | 30,141,642 | Jun 30, 2024 |
| JENNISON ASSOCIATES LLC | 4.72% | 0.02% | 2,757,579 | 1,109,882 | 67.36% | 28,403,063 | Jun 30, 2024 |
| ENSIGN PEAK ADVISORS, INC | 3.85% | 0.04% | 2,244,828 | -35,172 | -1.54% | 23,121,729 | Jun 30, 2024 |
| VANGUARD GROUP INC | 3.79% | 0.00% | 2,211,755 | 232,642 | 11.75% | 22,781,077 | Jun 30, 2024 |
| NEA MANAGEMENT COMPANY, LLC | 3.36% | 1.52% | 1,960,169 | - | - | 20,189,741 | Jun 30, 2024 |
| AVIDITY PARTNERS MANAGEMENT LP | 2.78% | 0.71% | 1,620,000 | -115,000 | -6.63% | 16,686,000 | Jun 30, 2024 |
| GILDER GAGNON HOWE & CO LLC | 2.52% | 0.19% | 1,472,259 | 454,642 | 44.68% | 15,164,268 | Jun 30, 2024 |
| 683 CAPITAL MANAGEMENT, LLC | 2.40% | 1.09% | 1,400,000 | -250,000 | -15.15% | 14,420,000 | Jun 30, 2024 |
| PORTOLAN CAPITAL MANAGEMENT, LLC | 1.94% | 0.96% | 1,130,089 | 1,130,089 | 100.00% | 11,639,917 | Jun 30, 2024 |
| CHECKPOINT CAPITAL L.P. | 1.50% | 5.43% | 875,000 | 429,839 | 96.56% | 9,012,500 | Jun 30, 2024 |
| PROPEL BIO MANAGEMENT, LLC | 1.49% | 5.81% | 869,927 | - | - | 8,960,248 | Jun 30, 2024 |
| DECHENG CAPITAL LLC | 1.46% | 2.68% | 850,000 | - | - | 8,755,000 | Jun 30, 2024 |
| KENNEDY CAPITAL MANAGEMENT LLC | 1.42% | 0.18% | 830,906 | 258,570 | 45.18% | 8,558,332 | Jun 30, 2024 |
| GEODE CAPITAL MANAGEMENT, LLC | 1.38% | 0.00% | 806,047 | 54,668 | 7.28% | 8,303,625 | Jun 30, 2024 |
| WOODLINE PARTNERS LP | 1.35% | 0.08% | 785,990 | 219,551 | 38.76% | 8,095,697 | Jun 30, 2024 |
| STATE STREET CORP | 1.35% | 0.00% | 785,249 | 68,048 | 9.49% | 8,088,065,000 | Jun 30, 2024 |
Phathom Pharmaceuticals's largest institutional shareholder is FRAZIER LIFE SCIENCES MANAGEMENT, L.P., holding 17.32% of the company's total share outstanding, currently valued at $104.13M. The top 10 institutional shareholders own together 64.99% of the company.
Institutional Shareholders by % of Total Assets
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| MEDICXI VENTURES MANAGEMENT (JERSEY) LTD | 12.79% | 22.93% | 7,464,572 | - | - | 76,885,092 | Jun 30, 2024 |
| PROPEL BIO MANAGEMENT, LLC | 1.49% | 5.81% | 869,927 | - | - | 8,960,248 | Jun 30, 2024 |
| CATALYS PACIFIC, LLC | 1.24% | 5.61% | 721,962 | - | - | 7,436,208 | Jun 30, 2024 |
| CHECKPOINT CAPITAL L.P. | 1.50% | 5.43% | 875,000 | 429,839 | 96.56% | 9,012,500 | Jun 30, 2024 |
| FRAZIER LIFE SCIENCES MANAGEMENT, L.P. | 17.32% | 4.87% | 10,109,279 | - | - | 104,125,574 | Jun 30, 2024 |
| CARLYLE GROUP INC. | 5.99% | 3.40% | 3,496,808 | - | - | 35,842,282 | Jun 30, 2024 |
| DECHENG CAPITAL LLC | 1.46% | 2.68% | 850,000 | - | - | 8,755,000 | Jun 30, 2024 |
| SATURN V CAPITAL MANAGEMENT LLC | 1.02% | 2.31% | 593,306 | 92,319 | 18.43% | 6,111,052 | Jun 30, 2024 |
| ORACLE INVESTMENT MANAGEMENT INC | 0.39% | 2.16% | 225,000 | 225,000 | 100.00% | 2,317,500 | Jun 30, 2024 |
| GHOST TREE CAPITAL, LLC | 1.03% | 1.94% | 600,000 | 115,000 | 23.71% | 6,180,000 | Jun 30, 2024 |
| NEA MANAGEMENT COMPANY, LLC | 3.36% | 1.52% | 1,960,169 | - | - | 20,189,741 | Jun 30, 2024 |
| PENN MUTUAL ASSET MANAGEMENT, LLC | 0.11% | 1.38% | 62,802 | - | - | 646,861 | Jun 30, 2024 |
| 683 CAPITAL MANAGEMENT, LLC | 2.40% | 1.09% | 1,400,000 | -250,000 | -15.15% | 14,420,000 | Jun 30, 2024 |
| PORTOLAN CAPITAL MANAGEMENT, LLC | 1.94% | 0.96% | 1,130,089 | 1,130,089 | 100.00% | 11,639,917 | Jun 30, 2024 |
| STEPSTONE GROUP LP | 0.72% | 0.88% | 422,085 | - | - | 4,347,476 | Jun 30, 2024 |
| AVIDITY PARTNERS MANAGEMENT LP | 2.78% | 0.71% | 1,620,000 | -115,000 | -6.63% | 16,686,000 | Jun 30, 2024 |
| SIMPLIFY ASSET MANAGEMENT INC. | 0.89% | 0.36% | 521,935 | - | - | 5,375,930 | Jun 30, 2024 |
| GILDER GAGNON HOWE & CO LLC | 2.52% | 0.19% | 1,472,259 | 454,642 | 44.68% | 15,164,268 | Jun 30, 2024 |
| KENNEDY CAPITAL MANAGEMENT LLC | 1.42% | 0.18% | 830,906 | 258,570 | 45.18% | 8,558,332 | Jun 30, 2024 |
| VIRTUS ETF ADVISERS LLC | 0.05% | 0.15% | 30,078 | 20,377 | 210.05% | 309,803 | Jun 30, 2024 |
The largest Phathom Pharmaceuticals shareholder by % of total assets is MEDICXI VENTURES MANAGEMENT (JERSEY) LTD. The company owns 7.46M shares of Phathom Pharmaceuticals (PHAT), representing 22.93% of its total assets.
Institutional Buyers
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| PORTOLAN CAPITAL MANAGEMENT, LLC | 1.94% | 0.96% | 1,130,089 | 1,130,089 | 100.00% | 11,639,917 | Jun 30, 2024 |
| JENNISON ASSOCIATES LLC | 4.72% | 0.02% | 2,757,579 | 1,109,882 | 67.36% | 28,403,063 | Jun 30, 2024 |
| MORGAN STANLEY | 1.31% | 0.00% | 762,597 | 525,437 | 221.55% | 7,854,749 | Jun 30, 2024 |
| GILDER GAGNON HOWE & CO LLC | 2.52% | 0.19% | 1,472,259 | 454,642 | 44.68% | 15,164,268 | Jun 30, 2024 |
| CHECKPOINT CAPITAL L.P. | 1.50% | 5.43% | 875,000 | 429,839 | 96.56% | 9,012,500 | Jun 30, 2024 |
| PRUDENTIAL FINANCIAL INC | 0.60% | 0.01% | 352,340 | 352,340 | 100.00% | 3,629,102 | Jun 30, 2024 |
| KENNEDY CAPITAL MANAGEMENT LLC | 1.42% | 0.18% | 830,906 | 258,570 | 45.18% | 8,558,332 | Jun 30, 2024 |
| VANGUARD GROUP INC | 3.79% | 0.00% | 2,211,755 | 232,642 | 11.75% | 22,781,077 | Jun 30, 2024 |
| ORACLE INVESTMENT MANAGEMENT INC | 0.39% | 2.16% | 225,000 | 225,000 | 100.00% | 2,317,500 | Jun 30, 2024 |
| WOODLINE PARTNERS LP | 1.35% | 0.08% | 785,990 | 219,551 | 38.76% | 8,095,697 | Jun 30, 2024 |
| GOLDMAN SACHS GROUP INC | 0.71% | 0.00% | 417,284 | 209,912 | 101.22% | 4,298,025 | Jun 30, 2024 |
| BLACKROCK INC. | 5.01% | 0.00% | 2,926,373 | 180,993 | 6.59% | 30,141,642 | Jun 30, 2024 |
| GHOST TREE CAPITAL, LLC | 1.03% | 1.94% | 600,000 | 115,000 | 23.71% | 6,180,000 | Jun 30, 2024 |
| MARSHALL WACE, LLP | 0.19% | 0.00% | 112,691 | 112,691 | 100.00% | 1,160,718 | Jun 30, 2024 |
| SATURN V CAPITAL MANAGEMENT LLC | 1.02% | 2.31% | 593,306 | 92,319 | 18.43% | 6,111,052 | Jun 30, 2024 |
| UBS ASSET MANAGEMENT AMERICAS INC | 0.16% | 0.00% | 93,154 | 80,261 | 622.52% | 959,488 | Jun 30, 2024 |
| STATE STREET CORP | 1.35% | 0.00% | 785,249 | 68,048 | 9.49% | 8,088,065,000 | Jun 30, 2024 |
| EAGLE ASSET MANAGEMENT INC | 0.62% | 0.02% | 361,463 | 56,624 | 18.58% | 3,907,415 | Jun 30, 2024 |
| GEODE CAPITAL MANAGEMENT, LLC | 1.38% | 0.00% | 806,047 | 54,668 | 7.28% | 8,303,625 | Jun 30, 2024 |
| STATE OF WISCONSIN INVESTMENT BOARD | 0.19% | 0.00% | 113,592 | 54,406 | 91.92% | 1,169,998 | Jun 30, 2024 |
As of Jun 30 2024, Phathom Pharmaceuticals's largest institutional buyer is PORTOLAN CAPITAL MANAGEMENT, LLC. The company purchased 1.13M stocks of PHAT, valued at $11.64M.
Institutional Sellers
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| OCTAGON CAPITAL ADVISORS LP | - | - | - | -455,000 | -100.00% | - | Jun 30, 2024 |
| 683 CAPITAL MANAGEMENT, LLC | 2.40% | 1.09% | 1,400,000 | -250,000 | -15.15% | 14,420,000 | Jun 30, 2024 |
| MILLENNIUM MANAGEMENT LLC | - | - | - | -225,024 | -100.00% | - | Jun 30, 2024 |
| NEWTYN MANAGEMENT, LLC | - | - | - | -165,000 | -100.00% | - | Jun 30, 2024 |
| TWO SIGMA INVESTMENTS, LP | 0.52% | 0.01% | 303,431 | -164,017 | -35.09% | 3,125,339 | Jun 30, 2024 |
| NUVEEN ASSET MANAGEMENT, LLC | 0.24% | 0.00% | 141,022 | -121,026 | -46.18% | 1,452,527 | Jun 30, 2024 |
| AVIDITY PARTNERS MANAGEMENT LP | 2.78% | 0.71% | 1,620,000 | -115,000 | -6.63% | 16,686,000 | Jun 30, 2024 |
| D. E. SHAW & CO., INC. | - | - | - | -64,138 | -100.00% | - | Jun 30, 2024 |
| ENSIGN PEAK ADVISORS, INC | 3.85% | 0.04% | 2,244,828 | -35,172 | -1.54% | 23,121,729 | Jun 30, 2024 |
| UBS OCONNOR LLC | - | - | - | -28,583 | -100.00% | - | Jun 30, 2024 |
| PRELUDE CAPITAL MANAGEMENT, LLC | - | - | - | -22,044 | -100.00% | - | Jun 30, 2024 |
| JACOBS LEVY EQUITY MANAGEMENT, INC | - | - | - | -20,987 | -100.00% | - | Jun 30, 2024 |
| SG AMERICAS SECURITIES, LLC | - | - | - | -18,873 | -100.00% | - | Jun 30, 2024 |
| INVESCO LTD. | 5.39% | 0.01% | 3,143,452 | -16,337 | -0.52% | 32,377,556 | Jun 30, 2024 |
| AMERICAN INTERNATIONAL GROUP, INC. | - | - | - | -15,802 | -100.00% | - | Jun 30, 2024 |
| BARCLAYS PLC | 0.02% | - | 12,405 | -15,794 | -56.01% | 128,000 | Jun 30, 2024 |
| MIRAE ASSET GLOBAL INVESTMENTS CO., LTD. | 0.00% | 0.00% | 1,748 | -12,158 | -87.43% | 18,179 | Jun 30, 2024 |
| ENTROPY TECHNOLOGIES, LP | - | - | - | -12,138 | -100.00% | - | Jun 30, 2024 |
| STATE BOARD OF ADMINISTRATION OF FLORIDA RETIREMENT SYSTEM | - | - | - | -11,228 | -100.00% | - | Jun 30, 2024 |
| ENTRYPOINT CAPITAL, LLC | 0.01% | 0.13% | 8,503 | -10,877 | -56.12% | 87,581 | Jun 30, 2024 |
As of Jun 30 2024, Phathom Pharmaceuticals's biggest institutional seller is OCTAGON CAPITAL ADVISORS LP. The company sold -0.46M shares of PHAT, valued at -.
Institutional New positions
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| PORTOLAN CAPITAL MANAGEMENT, LLC | 1.94% | 0.96% | 1,130,089 | 1,130,089 | 100.00% | 11,639,917 | Jun 30, 2024 |
| PRUDENTIAL FINANCIAL INC | 0.60% | 0.01% | 352,340 | 352,340 | 100.00% | 3,629,102 | Jun 30, 2024 |
| ORACLE INVESTMENT MANAGEMENT INC | 0.39% | 2.16% | 225,000 | 225,000 | 100.00% | 2,317,500 | Jun 30, 2024 |
| MARSHALL WACE, LLP | 0.19% | 0.00% | 112,691 | 112,691 | 100.00% | 1,160,718 | Jun 30, 2024 |
| MML INVESTORS SERVICES, LLC | 0.03% | 0.00% | 19,600 | 19,600 | 100.00% | 202,000 | Jun 30, 2024 |
| BREVAN HOWARD CAPITAL MANAGEMENT LP | 0.03% | 0.00% | 18,792 | 18,792 | 100.00% | 193,558 | Jun 30, 2024 |
| COREBRIDGE FINANCIAL, INC. | 0.03% | 0.00% | 18,358 | 18,358 | 100.00% | 189,087 | Jun 30, 2024 |
| MIRAE ASSET GLOBAL ETFS HOLDINGS LTD. | 0.03% | 0.00% | 16,270 | 16,270 | 100.00% | 167,581 | Jun 30, 2024 |
| BALYASNY ASSET MANAGEMENT L.P. | 0.03% | 0.00% | 15,006 | 15,006 | 100.00% | 154,562 | Jun 30, 2024 |
| LVW ADVISORS, LLC | 0.02% | 0.02% | 12,909 | 12,909 | 100.00% | 132,963 | Jun 30, 2024 |
| COMMONWEALTH EQUITY SERVICES, LLC | 0.02% | 0.00% | 11,596 | 11,596 | 100.00% | 119,000 | Jun 30, 2024 |
| AQUATIC CAPITAL MANAGEMENT LLC | 0.00% | 0.00% | 500 | 500 | 100.00% | 5,150 | Jun 30, 2024 |
| BESSEMER GROUP INC | 0.00% | - | 325 | 325 | 100.00% | 3,000 | Jun 30, 2024 |
| COMERICA BANK | 0.00% | - | 129 | 129 | 100.00% | 1,329 | Jun 30, 2024 |
| ROTHSCHILD INVESTMENT LLC | - | - | 20 | 20 | 100.00% | 206 | Jun 30, 2024 |
| SRS CAPITAL ADVISORS, INC. | - | - | 17 | 17 | 100.00% | 176 | Jun 30, 2024 |
Phathom Pharmaceuticals's largest new institutional shareholder by number of shares is PORTOLAN CAPITAL MANAGEMENT, LLC, purchased 1.13M shares, valued at $11.64M, as of undefined.
Institutional Sold Out
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| OCTAGON CAPITAL ADVISORS LP | - | - | - | -455,000 | -100.00% | - | Jun 30, 2024 |
| MILLENNIUM MANAGEMENT LLC | - | - | - | -225,024 | -100.00% | - | Jun 30, 2024 |
| NEWTYN MANAGEMENT, LLC | - | - | - | -165,000 | -100.00% | - | Jun 30, 2024 |
| D. E. SHAW & CO., INC. | - | - | - | -64,138 | -100.00% | - | Jun 30, 2024 |
| UBS OCONNOR LLC | - | - | - | -28,583 | -100.00% | - | Jun 30, 2024 |
| PRELUDE CAPITAL MANAGEMENT, LLC | - | - | - | -22,044 | -100.00% | - | Jun 30, 2024 |
| JACOBS LEVY EQUITY MANAGEMENT, INC | - | - | - | -20,987 | -100.00% | - | Jun 30, 2024 |
| SG AMERICAS SECURITIES, LLC | - | - | - | -18,873 | -100.00% | - | Jun 30, 2024 |
| AMERICAN INTERNATIONAL GROUP, INC. | - | - | - | -15,802 | -100.00% | - | Jun 30, 2024 |
| ENTROPY TECHNOLOGIES, LP | - | - | - | -12,138 | -100.00% | - | Jun 30, 2024 |
| STATE BOARD OF ADMINISTRATION OF FLORIDA RETIREMENT SYSTEM | - | - | - | -11,228 | -100.00% | - | Jun 30, 2024 |
| PRINCIPAL FINANCIAL GROUP INC | - | - | - | -10,783 | -100.00% | - | Jun 30, 2024 |
| METROPOLITAN LIFE INSURANCE CO/NY | - | - | - | -1,818 | -100.00% | - | Jun 30, 2024 |
| ICA GROUP WEALTH MANAGEMENT, LLC | - | - | - | -1,300 | -100.00% | - | Jun 30, 2024 |
| VESTCOR INC | - | - | - | -548 | -100.00% | - | Jun 30, 2024 |
| NELSON, VAN DENBURG & CAMPBELL WEALTH MANAGEMENT GROUP, LLC | - | - | - | -7 | -100.00% | - | Jun 30, 2024 |
Phathom Pharmaceuticals's largest sold out institutional shareholder by shares sold is OCTAGON CAPITAL ADVISORS LP, sold -0.46M shares, valued at -, as of undefined.
Phathom Pharmaceuticals Mutual Fund Holders
| Name | % Total Assets | Total Shares | Change Amount | Change % | Date |
|---|---|---|---|---|---|
| PRUDENTIAL SECTOR FUNDS, INC. | 0.20% | 417,422 | 417,422 | - | Feb 29, 2024 |
| Federated Hermes MDT Series | 0.06% | 159,626 | - | - | Jan 31, 2024 |
| AIM INTERNATIONAL MUTUAL FUNDS (INVESCO INTERNATIONAL MUTUAL FUNDS) | 0.05% | 1,733,665 | -11,709 | -0.67% | Jan 31, 2024 |
| VANGUARD VALLEY FORGE FUNDS | 0.05% | 25,360 | - | - | Mar 31, 2024 |
| STATE STREET INSTITUTIONAL FUNDS | 0.03% | 24,051 | - | - | Mar 31, 2024 |
| FIDELITY ADVISOR SERIES VII | 0.02% | 154,200 | - | - | Jan 31, 2024 |
| Simplify Exchange Traded Funds | 0.01% | 521,935 | 284,000 | 119.36% | Mar 28, 2024 |
| QUANTITATIVE MASTER SERIES LLC | 0.01% | 56,253 | - | - | Mar 31, 2024 |
| DEUTSCHE DWS INVESTMENTS VIT FUNDS | 0.01% | 5,004 | - | - | Mar 31, 2024 |
| AMG Funds IV | 0.01% | 19,748 | -200 | -1.00% | Jan 31, 2024 |
| ETFis Series Trust I | 0.01% | 9,189 | 1,445 | 18.66% | Jan 31, 2024 |
| Nushares ETF Trust | 0.00% | 32,960 | -494 | -1.48% | Jan 31, 2024 |
| VANGUARD INDEX FUNDS | 0.00% | 1,635,039 | -504,827 | -23.59% | Mar 31, 2024 |
| Fidelity Commonwealth Trust II | 0.00% | 22,840 | 22,840 | - | Aug 31, 2023 |
| Voya PARTNERS INC | 0.00% | 229,901 | - | - | Mar 31, 2024 |
| TIAA SEPARATE ACCOUNT VA 1 | 0.00% | 575 | - | - | Mar 31, 2024 |
| Humankind Benefit Corp | 0.00% | 54 | - | - | Dec 31, 2023 |
| SCHWAB CAPITAL TRUST | 0.00% | 85,911 | 3,403 | 4.12% | Jan 31, 2024 |
| FIDELITY CONCORD STREET TRUST | 0.00% | 331,767 | 10,477 | 3.26% | Feb 29, 2024 |
| JANUS INVESTMENT FUND | 0.00% | 421,939 | - | - | Dec 31, 2023 |
| MASSMUTUAL PREMIER FUNDS | 0.00% | 36,710 | -2,526 | -6.44% | Dec 31, 2023 |
| VANGUARD EXPLORER FUND | 0.00% | 15,061 | - | - | Jan 31, 2024 |
| Calvert Variable Products, Inc. | 0.00% | 3,095 | - | - | Mar 31, 2024 |
| FIDELITY COVINGTON TRUST | 0.00% | 14,125 | -225 | -1.57% | Jan 31, 2024 |
| VANGUARD INSTITUTIONAL INDEX FUNDS | 0.00% | 22,606 | -1,801 | -7.38% | Mar 31, 2024 |
| OHIO NATIONAL FUND INC | 0.00% | 14,533 | - | - | Mar 31, 2024 |
| GOLDMAN SACHS VARIABLE INSURANCE TRUST | 0.00% | 2,960 | -1,008 | -25.40% | Mar 31, 2024 |
| Principal Exchange-Traded Funds | 0.00% | 6,953 | -572 | -7.60% | Mar 31, 2024 |
| Chartwell Funds | 0.00% | 11,613 | 6,503 | 127.26% | Jun 30, 2022 |
| VANGUARD WORLD FUND | 0.00% | 97,060 | 3,983 | 4.28% | Feb 29, 2024 |
| Voya VARIABLE PORTFOLIOS INC | 0.00% | 11,019 | -1,824 | -14.20% | Mar 31, 2024 |
| STATE STREET VARIABLE INSURANCE SERIES FUNDS INC | 0.00% | 1,676 | - | - | Mar 31, 2024 |
| SCHWAB STRATEGIC TRUST | 0.00% | 181,708 | 15,421 | 9.27% | Feb 29, 2024 |
| Global X Funds | 0.00% | 12,207 | - | - | Jan 31, 2024 |
| Trust for Advised Portfolios | 0.00% | 5,101 | - | - | Dec 31, 2023 |
| MFS VARIABLE INSURANCE TRUST III | 0.00% | 4,093 | - | - | Mar 31, 2024 |
| Fidelity Rutland Square Trust II | 0.00% | 229,213 | - | - | Feb 29, 2024 |
| EQ ADVISORS TRUST | 0.00% | 221,312 | -5,592 | -2.46% | Mar 31, 2024 |
| SunAmerica Specialty Series | 0.00% | 89 | - | - | Apr 30, 2021 |
| AIM VARIABLE INSURANCE FUNDS (INVESCO VARIABLE INSURANCE FUNDS) | 0.00% | 393,078 | -639 | -0.16% | Mar 31, 2024 |
| STATE STREET INSTITUTIONAL INVESTMENT TRUST | 0.00% | 10,700 | - | - | Mar 31, 2024 |
| VARIABLE INSURANCE PRODUCTS FUND II | 0.00% | 1,885 | 247 | 15.08% | Mar 31, 2024 |
| TIAA-CREF LIFE FUNDS | 0.00% | 326 | -438 | -57.33% | Mar 31, 2024 |
| COLLEGE RETIREMENT EQUITIES FUND | 0.00% | 121,569 | - | - | Mar 31, 2024 |
| NORTHERN FUNDS | 0.00% | 14,402 | 820 | 6.04% | Mar 28, 2024 |
| T. Rowe Price Index Trust, Inc. | 0.00% | 2,123 | 184 | 9.49% | Mar 31, 2024 |
| NATIONWIDE VARIABLE INSURANCE TRUST | 0.00% | 11,717 | -50,262 | -81.10% | Mar 31, 2024 |
| iSHARES TRUST | 0.00% | 1,399,571 | -71,223 | -4.84% | Mar 31, 2024 |
| VANGUARD SCOTTSDALE FUNDS | 0.00% | 142,437 | 21,630 | 17.90% | Feb 29, 2024 |
| SA FUNDS INVESTMENT TRUST | 0.00% | 1,013 | - | - | Mar 31, 2024 |
| RYDEX SERIES FUNDS | 0.00% | 225 | - | - | Dec 31, 2023 |
| RUSSELL INVESTMENT FUNDS | 0.00% | 5,635 | - | - | Mar 31, 2024 |
| VANGUARD WELLINGTON FUND | 0.00% | 19,548 | - | - | Feb 29, 2024 |
| TIAA-CREF FUNDS | 0.00% | 147,301 | - | - | Jan 31, 2024 |
| RUSSELL INVESTMENT CO | 0.00% | 14,134 | 8,784 | 164.19% | Jan 31, 2024 |
| MAINSTAY FUNDS TRUST | 0.00% | 9,187 | 9,187 | - | Jan 31, 2024 |
| VALIC Co I | 0.00% | 12,305 | 408 | 3.43% | Feb 29, 2024 |
| PACIFIC FUNDS SERIES TRUST | 0.00% | 11,488 | - | - | Mar 31, 2023 |
| MUTUAL FUND SERIES TRUST | 0.00% | 160,000 | - | - | Mar 31, 2024 |
| DFA INVESTMENT DIMENSIONS GROUP INC | 0.00% | 37,997 | - | - | Jan 31, 2024 |
| MAINSTAY VP FUNDS TRUST | 0.00% | 4,581 | 4,581 | - | Mar 31, 2024 |
| Meeder Funds | 0.00% | 177 | - | - | Mar 31, 2024 |
| PROSHARES TRUST | 0.00% | 8,974 | 1,361 | 17.88% | Feb 29, 2024 |
| Brighthouse Funds Trust I | 0.00% | 216,312 | -3,505 | -1.59% | Mar 31, 2024 |
| RYDEX DYNAMIC FUNDS | 0.00% | 111 | - | - | Dec 31, 2023 |
| NATIONWIDE MUTUAL FUNDS | 0.00% | 3,535 | -45 | -1.26% | Jan 31, 2024 |
| PENN SERIES FUNDS INC | 0.00% | 700 | - | - | Mar 28, 2024 |
| RBB FUND, INC. | 0.00% | 2,157 | - | - | Feb 29, 2024 |
| ProFunds | 0.00% | 249 | -21 | -7.78% | Mar 31, 2024 |
| HC CAPITAL TRUST | 0.00% | 678 | - | - | Mar 31, 2024 |
| Guggenheim Active Allocation Fund | 0.00% | 120 | - | - | Feb 29, 2024 |
| Investment Managers Series Trust II | 0.00% | 220 | - | - | Mar 31, 2024 |
| JOHN HANCOCK VARIABLE INSURANCE TRUST | 0.00% | 37,979 | -1,163 | -2.97% | Mar 31, 2024 |
| MASTER INVESTMENT PORTFOLIO | 0.00% | 1,525 | - | - | Mar 31, 2024 |
| Direxion Shares ETF Trust | 0.00% | 2,511 | - | - | Jan 31, 2024 |
| USAA MUTUAL FUNDS TRUST | 0.00% | 3,560 | 688 | 23.96% | Jan 31, 2024 |
| ALLIANZ VARIABLE INSURANCE PRODUCTS TRUST | 0.00% | 800 | - | - | Dec 31, 2023 |
| RYDEX VARIABLE TRUST | 0.00% | 15 | - | - | Dec 31, 2023 |
| Brighthouse Funds Trust II | 0.00% | 10,477 | - | - | Mar 31, 2024 |
| SPDR INDEX SHARES FUNDS | 0.00% | 2,238 | 135 | 6.42% | Mar 31, 2024 |
| PGIM ETF TRUST | 0.00% | 736 | - | - | Feb 29, 2024 |
| John Hancock Funds II | 0.00% | 161,865 | -4,165 | -2.51% | Feb 29, 2024 |
| J.P. Morgan Exchange-Traded Fund Trust | 0.00% | 4,759 | - | - | Jan 31, 2024 |
| MORGAN STANLEY PATHWAY FUNDS | 0.00% | 1,080 | - | - | Feb 29, 2024 |
| LINCOLN VARIABLE INSURANCE PRODUCTS TRUST | 0.00% | 26,100 | - | - | Mar 31, 2024 |
| SUNAMERICA SERIES TRUST | 0.00% | 3,633 | 121 | 3.45% | Jan 31, 2024 |
| Brinker Capital Destinations Trust | 0.00% | 578 | - | - | Feb 29, 2024 |
| Goldman Sachs ETF Trust | 0.00% | 807 | -6,856 | -89.47% | Feb 29, 2024 |
| PUTNAM ASSET ALLOCATION FUNDS | 0.00% | 252 | - | - | Mar 31, 2024 |
| AMERICAN CENTURY ETF TRUST | 0.00% | 748 | - | - | Feb 29, 2024 |
| FIDELITY SALEM STREET TRUST | 0.00% | 21,579 | -104 | -0.48% | Mar 31, 2024 |
| ETF Series Solutions | 0.00% | 108 | - | - | Jan 31, 2024 |
| Invesco Exchange-Traded Fund Trust II | 0.00% | 1,526 | 540 | 54.77% | Feb 29, 2024 |
| SEI INSTITUTIONAL MANAGED TRUST | 0.00% | 11,481 | - | - | Dec 31, 2023 |
| PACIFIC SELECT FUND | 0.00% | 11,575 | -236 | -2.00% | Mar 31, 2024 |
| Bridge Builder Trust | 0.00% | 10,831 | - | - | Mar 31, 2024 |
| Dimensional ETF Trust | 0.00% | 982 | - | - | Jan 31, 2024 |
| SPDR SERIES TRUST | 0.00% | 69,960 | - | - | Mar 31, 2024 |
| Blackstone Alternative Investment Funds | 0.00% | 100 | - | - | Mar 31, 2023 |
| Invesco Exchange-Traded Self-Indexed Fund Trust | 0.00% | 360 | - | - | Feb 29, 2024 |
Phathom Pharmaceuticals's largest mutual fund holder by % of total assets is "PRUDENTIAL SECTOR FUNDS, INC.", owning 417.42K shares, compromising 0.20% of its total assets.
Phathom Pharmaceuticals Institutional Ownership Trends
Institutional Holdings Trend
| Date | Holdings | Change % |
|---|---|---|
| 30 Jun, 24 | 35 | -70.09% |
| 31 Mar, 24 | 117 | -2.50% |
| 31 Dec, 23 | 120 | 6.19% |
| 30 Sep, 23 | 113 | 4.63% |
| 30 Jun, 23 | 108 | 24.14% |
| 31 Mar, 23 | 87 | -1.14% |
| 31 Dec, 22 | 88 | -2.22% |
| 30 Sep, 22 | 90 | -2.17% |
| 30 Jun, 22 | 92 | 10.84% |
| 31 Mar, 22 | 83 | - |
| 31 Dec, 21 | 83 | - |
| 30 Sep, 21 | 83 | 6.41% |
| 30 Jun, 21 | 78 | -7.14% |
| 31 Mar, 21 | 84 | 9.09% |
| 31 Dec, 20 | 77 | 35.09% |
| 30 Sep, 20 | 57 | -5.00% |
| 30 Jun, 20 | 60 | 27.66% |
| 31 Mar, 20 | 47 | 14.63% |
| 31 Dec, 19 | 41 | - |
As of 30 Jun 24, 35 institutions are holding Phathom Pharmaceuticals's shares, representing a decrease of -70.09% compared to the previous quarter.
Shares Outstanding Trend
| Date | Shares Outstanding | Change % |
|---|---|---|
| 30 Jun, 24 | 15,104,541 | -71.09% |
| 31 Mar, 24 | 52,249,167 | 11.99% |
| 31 Dec, 23 | 46,653,575 | 6.61% |
| 30 Sep, 23 | 43,760,270 | 2.29% |
| 30 Jun, 23 | 42,778,866 | 38.95% |
| 31 Mar, 23 | 30,786,894 | 8.53% |
| 31 Dec, 22 | 28,368,434 | -6.02% |
| 30 Sep, 22 | 30,185,993 | 10.40% |
| 30 Jun, 22 | 27,342,190 | 6.42% |
| 31 Mar, 22 | 25,692,967 | -10.08% |
| 31 Dec, 21 | 28,574,495 | 11.87% |
| 30 Sep, 21 | 25,543,686 | 2.51% |
| 30 Jun, 21 | 24,919,005 | 1.81% |
| 31 Mar, 21 | 24,475,880 | -0.24% |
| 31 Dec, 20 | 24,534,168 | 13.42% |
| 30 Sep, 20 | 21,631,992 | -0.99% |
| 30 Jun, 20 | 21,847,194 | -0.47% |
| 31 Mar, 20 | 21,949,539 | 0.63% |
| 31 Dec, 19 | 21,811,276 | - |
Phathom Pharmaceuticals (PHAT) has 15.10M shares outstanding as of 30 Jun 24, down -71.09% compared to the previous quarter.
Institutional Ownership Trend
| Date | Ownership % | Change % |
|---|---|---|
| 30 Jun, 24 | 25.88% | 0.31% |
| 31 Mar, 24 | 91.19% | 1.35% |
| 31 Dec, 23 | 82.16% | 1.01% |
| 30 Sep, 23 | 90.23% | 0.88% |
| 30 Jun, 23 | 101.00% | 1.91% |
| 31 Mar, 23 | 72.69% | 1.54% |
| 31 Dec, 22 | 68.67% | 1.14% |
| 30 Sep, 22 | 77.76% | 1.52% |
| 30 Jun, 22 | 71.44% | 1.57% |
| 31 Mar, 22 | 67.55% | 1.13% |
| 31 Dec, 21 | 77.22% | 1.65% |
| 30 Sep, 21 | 68.48% | 1.48% |
| 30 Jun, 21 | 68.02% | 1.50% |
| 31 Mar, 21 | 67.43% | 1.30% |
| 31 Dec, 20 | 72.03% | 1.71% |
| 30 Sep, 20 | 64.83% | 1.48% |
| 30 Jun, 20 | 66.21% | 1.45% |
| 31 Mar, 20 | 67.60% | 1.50% |
| 31 Dec, 19 | 67.17% | - |
As of 30 Jun 24, Phathom Pharmaceuticals is held by 25.88% institutional shareholders, representing a 0.31% growth compared to 31 Mar 24.
Institutional Increased Positions Trend
| Date | Increased Positions | Change % |
|---|---|---|
| 30 Jun, 24 | 17 | -67.92% |
| 31 Mar, 24 | 53 | -28.38% |
| 31 Dec, 23 | 74 | 17.46% |
| 30 Sep, 23 | 63 | -7.35% |
| 30 Jun, 23 | 68 | 41.67% |
| 31 Mar, 23 | 48 | 26.32% |
| 31 Dec, 22 | 38 | -22.45% |
| 30 Sep, 22 | 49 | -5.77% |
| 30 Jun, 22 | 52 | 15.56% |
| 31 Mar, 22 | 45 | -11.76% |
| 31 Dec, 21 | 51 | 50.00% |
| 30 Sep, 21 | 34 | -24.44% |
| 30 Jun, 21 | 45 | 4.65% |
| 31 Mar, 21 | 43 | -6.52% |
| 31 Dec, 20 | 46 | 228.57% |
| 30 Sep, 20 | 14 | -65.00% |
| 30 Jun, 20 | 40 | 53.85% |
| 31 Mar, 20 | 26 | -36.59% |
| 31 Dec, 19 | 41 | - |
17 institutional shareholders have increased their position in PHAT stock as of 30 Jun 24 compared to 53 in the previous quarter (a -67.92% decrease).
Institutional Reduced Positions Trend
| Date | Reduced Positions | Change % |
|---|---|---|
| 30 Jun, 24 | 5 | -85.29% |
| 31 Mar, 24 | 34 | 47.83% |
| 31 Dec, 23 | 23 | -4.17% |
| 30 Sep, 23 | 24 | 20.00% |
| 30 Jun, 23 | 20 | 5.26% |
| 31 Mar, 23 | 19 | -29.63% |
| 31 Dec, 22 | 27 | 12.50% |
| 30 Sep, 22 | 24 | 9.09% |
| 30 Jun, 22 | 22 | -8.33% |
| 31 Mar, 22 | 24 | 84.62% |
| 31 Dec, 21 | 13 | -43.48% |
| 30 Sep, 21 | 23 | 53.33% |
| 30 Jun, 21 | 15 | -34.78% |
| 31 Mar, 21 | 23 | 53.33% |
| 31 Dec, 20 | 15 | -34.78% |
| 30 Sep, 20 | 23 | 228.57% |
| 30 Jun, 20 | 7 | -41.67% |
| 31 Mar, 20 | 12 | - |
| 31 Dec, 19 | - | - |
5 institutional shareholders have reduced their position in PHAT stock as of 30 Jun 24 compared to 34 in the previous quarter (a -85.29% decrease).
All Institutional Ownership Trend Data
| Date | Holdings | Change % | Shares Outstanding | Change % | Ownership % | Change % | Increased Positions | Change % | Reduced Positions | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| 30 Jun, 24 | 35 | -70.09% | 15,104,541 | -71.09% | 25.88% | 0.31% | 17 | -67.92% | 5 | -85.29% |
| 31 Mar, 24 | 117 | -2.50% | 52,249,167 | 11.99% | 91.19% | 1.35% | 53 | -28.38% | 34 | 47.83% |
| 31 Dec, 23 | 120 | 6.19% | 46,653,575 | 6.61% | 82.16% | 1.01% | 74 | 17.46% | 23 | -4.17% |
| 30 Sep, 23 | 113 | 4.63% | 43,760,270 | 2.29% | 90.23% | 0.88% | 63 | -7.35% | 24 | 20.00% |
| 30 Jun, 23 | 108 | 24.14% | 42,778,866 | 38.95% | 101.00% | 1.91% | 68 | 41.67% | 20 | 5.26% |
| 31 Mar, 23 | 87 | -1.14% | 30,786,894 | 8.53% | 72.69% | 1.54% | 48 | 26.32% | 19 | -29.63% |
| 31 Dec, 22 | 88 | -2.22% | 28,368,434 | -6.02% | 68.67% | 1.14% | 38 | -22.45% | 27 | 12.50% |
| 30 Sep, 22 | 90 | -2.17% | 30,185,993 | 10.40% | 77.76% | 1.52% | 49 | -5.77% | 24 | 9.09% |
| 30 Jun, 22 | 92 | 10.84% | 27,342,190 | 6.42% | 71.44% | 1.57% | 52 | 15.56% | 22 | -8.33% |
| 31 Mar, 22 | 83 | - | 25,692,967 | -10.08% | 67.55% | 1.13% | 45 | -11.76% | 24 | 84.62% |
| 31 Dec, 21 | 83 | - | 28,574,495 | 11.87% | 77.22% | 1.65% | 51 | 50.00% | 13 | -43.48% |
| 30 Sep, 21 | 83 | 6.41% | 25,543,686 | 2.51% | 68.48% | 1.48% | 34 | -24.44% | 23 | 53.33% |
| 30 Jun, 21 | 78 | -7.14% | 24,919,005 | 1.81% | 68.02% | 1.50% | 45 | 4.65% | 15 | -34.78% |
| 31 Mar, 21 | 84 | 9.09% | 24,475,880 | -0.24% | 67.43% | 1.30% | 43 | -6.52% | 23 | 53.33% |
| 31 Dec, 20 | 77 | 35.09% | 24,534,168 | 13.42% | 72.03% | 1.71% | 46 | 228.57% | 15 | -34.78% |
| 30 Sep, 20 | 57 | -5.00% | 21,631,992 | -0.99% | 64.83% | 1.48% | 14 | -65.00% | 23 | 228.57% |
| 30 Jun, 20 | 60 | 27.66% | 21,847,194 | -0.47% | 66.21% | 1.45% | 40 | 53.85% | 7 | -41.67% |
| 31 Mar, 20 | 47 | 14.63% | 21,949,539 | 0.63% | 67.60% | 1.50% | 26 | -36.59% | 12 | - |
| 31 Dec, 19 | 41 | - | 21,811,276 | - | 67.17% | - | 41 | - | - | - |
Phathom Pharmaceuticals Insider Shareholders Trades
Open Market Insider Trades
Open Market Insider Buys
| Date | Name | Relation | Role | Transaction | Buy/Sell | Shares | Price | Value | Shares Held | Source |
|---|
Insider Sells
All Insider Owners Trades
The last insider sell of Phathom Pharmaceuticals's stock was made by Nabulsi Azmi on Jul 17 2024, selling 10,901 shares at $11.72 per share (valued at $127.76K).
Phathom Pharmaceuticals Insider Ownership Trends
All Insider Trades Trend
| Date | Buy | Sell | Buy/Sell Ratio |
|---|---|---|---|
| Q3 2024 | - | 3 | - |
| Q2 2024 | 10 | 8 | 125.00% |
| Q1 2024 | 3 | 3 | 100.00% |
| Q4 2023 | 6 | 3 | 200.00% |
| Q3 2023 | 4 | 4 | 100.00% |
| Q2 2023 | 18 | 4 | 450.00% |
| Q1 2023 | 8 | 3 | 266.67% |
| Q4 2022 | - | 2 | - |
| Q3 2022 | 4 | - | - |
| Q2 2022 | 23 | - | - |
| Q1 2022 | 7 | 2 | 350.00% |
| Q4 2021 | 1 | 5 | 20.00% |
| Q3 2021 | 1 | 8 | 12.50% |
| Q2 2021 | 6 | 74 | 8.11% |
| Q1 2021 | 4 | 32 | 12.50% |
| Q4 2020 | - | 21 | - |
| Q3 2020 | 3 | - | - |
| Q2 2020 | 6 | 2 | 300.00% |
| Q1 2020 | 3 | 4 | 75.00% |
| Q4 2019 | 7 | 12 | 58.33% |
0 total buy trades, and 3 total sell trades (buy/sell ratio of 0.00%) were made by Phathom Pharmaceuticals's insiders, as of Q3 2024.
Open Market Insider Trades Trend
| Date | Buy | Sell | Buy/Sell Ratio |
|---|---|---|---|
| Q3 2024 | - | 3 | - |
| Q2 2024 | - | 1 | - |
| Q1 2024 | - | 3 | - |
| Q4 2023 | 3 | 3 | 100.00% |
| Q3 2023 | - | - | - |
| Q2 2023 | 3 | 3 | 100.00% |
| Q1 2023 | 2 | 3 | 66.67% |
| Q4 2022 | - | 2 | - |
| Q3 2022 | - | - | - |
| Q2 2022 | 5 | - | - |
| Q1 2022 | - | 1 | - |
| Q4 2021 | - | 4 | - |
| Q3 2021 | - | 8 | - |
| Q2 2021 | - | 70 | - |
| Q1 2021 | - | 31 | - |
| Q4 2020 | - | 21 | - |
| Q3 2020 | - | - | - |
| Q2 2020 | 1 | - | - |
| Q1 2020 | 2 | 4 | 50.00% |
| Q4 2019 | 4 | - | - |
As of Q3 2024, Insider owners conducted 0 open market buy trades and 3 open market sell trades of Phathom Pharmaceuticals's stocks.
Phathom Pharmaceuticals Peer Ownership
| Ticker | Company |
|---|---|
| XFOR | X4 Pharmaceuticals, Inc. |
| CNSP | CNS Pharmaceuticals, Inc. |
| CGEM | Cullinan Oncology, Inc. |
| VECT | VectivBio Holding AG |
| KNSA | Kiniksa Pharmaceuticals, Ltd. |
| BPMC | Blueprint Medicines Corporation |
| DAWN | Day One Biopharmaceuticals, Inc. |
| AVRO | AVROBIO, Inc. |
| TERN | Terns Pharmaceuticals, Inc. |
| INZY | Inozyme Pharma, Inc. |
| IMMX | Immix Biopharma, Inc. |
| ABOS | Acumen Pharmaceuticals, Inc. |
| GPCR | Structure Therapeutics Inc. |
| HEPA | Hepion Pharmaceuticals, Inc. |
| KRTX | Karuna Therapeutics, Inc. |
| LYRA | Lyra Therapeutics, Inc. |
| AMLX | Amylyx Pharmaceuticals, Inc. |
PHAT Ownership FAQ
Who Owns Phathom Pharmaceuticals?
Phathom Pharmaceuticals is owned by institutional shareholders (25.88%), insiders (7.82%), and public (66.30%). The largest institutional shareholder of Phathom Pharmaceuticals is FRAZIER LIFE SCIENCES MANAGEMENT, L.P. (17.32% of total shares) and the top mutual fund owner is PRUDENTIAL SECTOR FUNDS, INC. (0.20% of total shares).
Who are the major institutional shareholders of Phathom Pharmaceuticals?
Phathom Pharmaceuticals's major institutional shareholders are FRAZIER LIFE SCIENCES MANAGEMENT, L.P., MEDICXI VENTURES MANAGEMENT (JERSEY) LTD, CARLYLE GROUP INC., INVESCO LTD., and BLACKROCK INC.. The top five shareholders own together 46.50% of the company's share outstanding.
How many Phathom Pharmaceuticals shareholders are there?
As of Jun 2024, there are 35 institutional shareholders of Phathom Pharmaceuticals.
What percentage of Phathom Pharmaceuticals is owned by FRAZIER LIFE SCIENCES MANAGEMENT, L.P?
FRAZIER LIFE SCIENCES MANAGEMENT, L.P owns 10.11M shares of Phathom Pharmaceuticals, representing 17.32% of the company's total shares outstanding, valued at $104.13M (as of Jun 2024).
What percentage of Phathom Pharmaceuticals is owned by MEDICXI VENTURES MANAGEMENT (JERSEY) LTD?
As of Jun 2024, MEDICXI VENTURES MANAGEMENT (JERSEY) LTD holds 7.46M shares of Phathom Pharmaceuticals (PHAT), compromising 12.79% of the company, valued at $76.89M.
What percentage of Phathom Pharmaceuticals is owned by CARLYLE GROUP INC?
CARLYLE GROUP INC is the third largest holder of Phathom Pharmaceuticals. The company owns 3.5M of the company's shares outstanding (worth $35.84M).